Astrocytic ET-1 System Determines Microglia Phenotype Following Spinal Cord Injury

Bingqiang He1,2, Si Xu1, Mengdi Li1

  • 1Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong, 226001, P.R. China.

Insights

Spinal cord injury triggers astrocytic endothelin-1 (ET-1) system activation, promoting harmful M1 microglia polarization. Targeting this ET-1 system with inhibitors improves locomotor function recovery in rats.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Microglia/macrophages adopt a pro-inflammatory M1 phenotype post-spinal cord injury (SCI), exacerbating tissue damage.
  • This M1 polarization is a critical factor influencing functional outcomes after SCI.

Purpose of the Study:

  • To elucidate the role of the astrocytic endothelin-1 (ET-1) system in microglia polarization following SCI.
  • To identify the upstream activators and downstream signaling pathways involved in astrocytic ET-1 system activation.
  • To evaluate the therapeutic potential of targeting the astrocytic ET-1 system for SCI recovery.

Main Methods:

  • Investigated the activation of the astrocytic ET-1 system immediately after SCI in a rat model.
  • Utilized pharmacological inhibitors for protease-activated receptor-1 (PAR-1) and ET-1.
  • Assessed microglia phenotype (M1/M2), ET-1 plasma levels, and locomotor function recovery.

Main Results:

  • Astrocytic ET-1 system activation drives M1 microglia polarization and suppresses M2 phenotype via YAP activation.
  • SCI-induced thrombin activates the astrocytic ET-1 system through PAR-1 signaling pathways.
  • Inhibition of PAR-1 and ET-1 effectively reversed M1 microglia phenotype and improved locomotor function in rats.

Conclusions:

  • A novel mechanism involving the astrocytic ET-1 system in M1 microglia/macrophage accumulation post-SCI was uncovered.
  • The astrocytic ET-1 system, activated by thrombin, represents a potential therapeutic target for neuroinflammation and functional recovery after SCI.